DHR vs NFLX: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Netflix, Inc. β fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation Β· Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Netflix, Inc. Β· Communication Services
$91.02
+95.7% upside to fair value
Grade B
High Quality
QuantHub Verdict
NFLX has more upside to fair value
(+95.7%).
NFLX trades at a lower forward P/E
(28.7x).
These are model outputs β not personalized investment advice.
See all research β
Valuation & Fundamentals
| Metric |
DHR |
NFLX |
| Current Price |
$174.04 |
$91.02 |
| Fair Value Estimate |
$197.01 |
$178.10 |
| Upside to Fair Value |
+13.2%
|
+95.7%
|
| Market Cap |
$123.2B |
$383.3B |
| Forward P/E |
33.4x
|
28.7x
|
| EV / EBITDA |
20.3x
|
11.4x
|
| Price / Sales |
5.0x
|
8.2x
|
| Price / FCF |
23.3x
|
32.2x
|
| Revenue Growth YoY |
+3.7%
|
+16.2%
|
| Gross Margin |
60.7%
|
49.0%
|
| Operating Margin |
21.0%
|
29.7%
|
| Return on Equity |
7.1%
|
49.2%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
3.1%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record incβ¦
Netflix, Inc. operates a leading global streaming entertainment service with a dominant streaming segment accounting for nearly 100% of its revenue. The company benefits from a high-quality business model characterized by strong revenue growth of 16.2% and earnings growth of 82.8% in the most recent quarter, a robust 49.2% return on equity, and healthy margins with a 29.7% operating margin and 28β¦
Accumulation Zones
| Metric |
DHR |
NFLX |
| Zone Low |
$147.76 |
$133.57 |
| Zone High |
$167.46 |
$151.38 |
| In Buy Zone? |
No
|
Yes
|